Loading

Welcome to ProBioGen

Providing Intelligent Biopharmaceutical Solutions

LATEST NEWS

Ceva Takes Commercial License for ProBioGen's AGE1.CR® Cell Line for Viral Vaccine Production

ProBioGen and Inhibrx Sign License Deal on GlymaxX® ADCC Technology for Therapeutic Antibodies Development

UPCOMING EVENTS

14.06.2012

Copenhagen, Denmark

18.06.2012 - 21.06.2012

Boston, MA, USA